We are live on ! Find out more

496 hedge funds and large institutions have $12.4B invested in Sanofi in 2014 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 188 increasing their positions, 152 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 38

30% more funds holding in top 10

Funds holding in top 10: 1013 (+3)

24% more repeat investments, than reductions

Existing positions increased: 188 | Existing positions reduced: 152

10% more call options, than puts

Call options by funds: $65.9M | Put options by funds: $59.9M

2% more funds holding

Funds holding: 486496 (+10)

3% more capital invested

Capital invested by funds: $12.1B → $12.4B (+$310M)

0.98% more ownership

Funds ownership: 17%17.98% (+0.98%)

Holders
496
Holders Change
+10
Holders Change %
+2.06%
% of All Funds
14.32%
Holding in Top 10
13
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+30%
% of All Funds
0.38%
New
54
Increased
188
Reduced
152
Closed
38
Calls
$65.9M
Puts
$59.9M
Net Calls
+$6.02M
Net Calls Change
+$454K
Name Holding Trade Value Shares
Change
Change in
Stake
Lazard Asset Management
26
Lazard Asset Management
New York
$94M +$8.73M +172,548 +11%
Neuberger Berman Group
27
Neuberger Berman Group
New York
$87.3M -$49.2M -971,427 -37%
JP Morgan Chase
28
JP Morgan Chase
New York
$85.6M +$5.53M +109,211 +7%
O
29
OppenheimerFunds
New York
$83.4M +$15M +295,720 +23%
Arrowstreet Capital
30
Arrowstreet Capital
Massachusetts
$74.1M +$9.7M +191,603 +16%
Wells Fargo
31
Wells Fargo
California
$72.2M -$1.71M -33,729 -2%
OCM
32
Osterweis Capital Management
California
$68.6M +$49M +968,775 +282%
Goldman Sachs
33
Goldman Sachs
New York
$65.1M -$69.1M -1,365,024 -52%
CS
34
Credit Suisse
Switzerland
$64.7M +$16.9K +333 +0%
EVM
35
Eaton Vance Management
Massachusetts
$62.6M -$7.08M -139,962 -10%
AC
36
Amici Capital
New York
$60.5M +$101K +2,000 +0.2%
U
37
UBS
Switzerland
$57.4M -$158M -3,121,265 -74%
RFC
38
Russell Frank Company
Washington
$53.6M +$3.19M +63,067 +7%
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$53.1M -$1.42M -28,149 -3%
PPA
40
Parametric Portfolio Associates
Washington
$50.7M +$3.25M +64,109 +7%
BA
41
BlackRock Advisors
Delaware
$49M +$36.6M +722,131 +335%
JFL
42
Jarislowsky, Fraser Ltd
Quebec, Canada
$45.5M +$2.7M +53,275 +7%
HI
43
Honeywell International
North Carolina
$44.6M -$12.8M -253,000 -23%
MDSL
44
M.D. Sass LLC
New York
$44.5M -$2.67M -52,790 -6%
PI
45
Putnam Investments
Massachusetts
$44M -$25.3M -499,350 -37%
RCM
46
RNC Capital Management
California
$40.4M +$3.18M +62,770 +9%
MIP
47
Mondrian Investment Partners
United Kingdom
$39M +$2.83M +56,000 +8%
Allianz Asset Management
48
Allianz Asset Management
Germany
$39M -$315K -6,225 -0.8%
TGI
49
Tradewinds Global Investors
California
$38.5M -$330K -6,529 -0.9%
Dimensional Fund Advisors
50
Dimensional Fund Advisors
Texas
$38.2M -$5.57M -109,940 -13%

SNY Hedge Fund Activity: Q1 2014 in Review

496 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2014, worth a combined $12.4B — up 2.6% from $12.1B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new SNY positions and 38 closed out — a net gain of 16 holders — while 188 added to existing stakes and 152 trimmed.

The largest buyer was Barrow, Hanley, Mewhinney & Strauss, adding an estimated $260M. The largest seller was UBS, cutting an estimated $158M.

  • 496 institutional investors held Sanofi (SNY) as of Q1 2014, up from 486 in Q4 2013.
  • Funds reported $12.4B of Sanofi stock for Q1 2014, up 2.6% quarter-over-quarter.
  • 54 funds opened new Sanofi positions in Q1 2014 and 38 closed out, a net change of +16 holders.
  • The largest Sanofi buyer in Q1 2014 was Barrow, Hanley, Mewhinney & Strauss, an estimated $260M added.
  • The largest Sanofi seller in Q1 2014 was UBS, an estimated $158M sold.

Based on aggregated 13F filings for Q1 2014.